Trial Profile
Safety and efficacy of Ranibizumab in South Asian patients with Diabetic macular oedema (DMO): A real-life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- Acronyms ADMOR
- 20 Oct 2016 New trial record